Helping businesses succeed by placing key specialists to build leadership teams
The Compass Carter Osborne consultants have worked across the drug development sector, helping businesses succeed by placing key individual scientific, clinical, and commercial specialists, through the provision of building leadership teams.
Our deep appreciation of the interrelationships between clinical stage biotechnology companies, their research partners, and potential future commercial relationships, whether in speciality firms or global pharmaceuticals enables us to identify and evaluate the most capable candidates. CCO work with investors and company leadership teams to secure leading talent as companies approach inflection points in their growth and development.
Speciality firms, global pharma companies and generic manufacturers continuously evolve as they seek to meet patient needs across complex global markets. Identifying future leaders and enabling careers across the sector is a key driver of success. We have supported peoples’ careers within established specialisms and facilitated movement, whether across geographic boundaries or between sub-sectors of the industry.
Event: What is the next big innovation coming to Life Sciences?
In our most recent round table, we welcomed a cohort of industry leaders to discuss where the next big innovation in the Life Sciences sector is coming from.
Addressing a broad range of topics, panelists addressed questions on biotech funding bounce-back; investment appetite in innovative technologies; quantum computing and AI and driving positive outcomes for the sector.
Compass Carter Osborne Director, Tarquin Bennet-Coles, will be attending the LSX Investival Showcase this November in London.
The 2024 LSX Investival Showcase is a major event for the life sciences industry, set to take place on November 18, 2024, at Tobacco Dock in London. This event is part of Europe’s largest healthcare investment week, designed to connect life science and healthcare executives with global investors, partners, and deal-makers.
Compass Carter Osborne was engaged by Hengrui Therapeutics to source a Vice President – Head of European Research Centre, Biological Drug Discovery to be responsible for building a preclinical discovery science lab in Switzerland
“Compass Carter Osborne started from the very beginning with a detailed, professional explanation of the available position. They spent time to present the great opportunity and chance to accelerate my career but at the same time, the challenge, and the strong expectation from their client.
They patiently listened to my introduction and clearly identified and commented on important points for his client, my personal development and further presentation to my current company Hengrui. In the end, it was more like a joint project than a recruitment process. The chance to be part of the Hengrui scientific and therapeutic development and expansion in Europe for future therapies development for the benefit of both the patients and the company represents for me not only a challenge and pleasure but also an honour.
The professionalism I received during the recruitment process thanks to Compass Carter Osborne was warm and friendly, and I can recommend them without hesitation.”
Hengrui Therapeutics – Head Biological Drug Discovery
“We engaged Alex to help us find a Global VP for our Supply Chain transformation at a pivotal point in the global transformation of our organisation, he proved to be an adept and diligent consultant to our EVP of Supply Chain and worked at pace to deliver a high-quality shortlist when the role had been open for 6 months already with another search firm.
The stand-out candidate that was liked across the team was identified in the process as a high potential leader for the business and we decided to put him through our executive leadership assessment programme and ultimately hired him at SVP level and he became the successor to our EVP. Alex impressed us with his ability to really listen to the needs of the business and the relevant stakeholders throughout the process.”
Global Specialty Pharma – Europe Global Head of HR
“The team did an excellent job in delivering a strong group of candidates for such a critical role as CEO, reflecting positively on their expertise and dedication to their clients’ needs. Their process has left a positive impression, further solidifying their reputation in the industry.”
